secwatch / observer
8-K filed June 24, 2026, 4:07 PM ET ticker KYMR CIK 0001815442
other confidence high sentiment neutral materiality 0.15

Kymera annual meeting results: all Class III directors elected, say-on-pay approved, EY ratified

Kymera Therapeutics, Inc.

Kymera Therapeutics, Inc. filing history →

Source: SEC EDGAR
accession 0001193125-26-281051
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.